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The fundamental role of D-serine as a co-agonist at the N-methyl-D-aspartate receptor
(NMDAR), mediating both physiological actions of glutamate in long term potentiation and
nociception and also pathological effects mediated by excitotoxicty, are well-established.
More recently, a direct link to a chronic neurodegenerative disease, amyotrophic lateral
sclerosis/motor neuron disease (ALS) has been suggested by findings that D-serine levels
are elevated in sporadic ALS and the G93A SOD1 model of ALS (Sasabe et al., 2007,
2012) and that a pathogenic mutation (R199W) in the enzyme that degrades D-serine,
D-amino acid oxidase (DAO), co-segregates with disease in familial ALS (Mitchell et al.,
2010). Moreover, D-serine, its biosynthetic enzyme, serine racemase (SR) and DAO are
abundant in human spinal cord and severely depleted in ALS. Using cell culture models,
we have defined the effects of R199W-DAO, and shown that it activates autophagy,
leads to the formation of ubiquitinated aggregates and promotes apoptosis, all of which
processes are attenuated by a D-serine/glycine site NMDAR antagonist. These studies
provide considerable insight into the crosstalk between neurons and glia and also into
potential therapeutic approaches for ALS.
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IDENTIFICATION OF A MUTATION IN D-AMINO ACID
OXIDASE (DAO) IN FAMILIAL ALS
It has only recently been recognized that D-amino acids play an
important physiological role in the central nervous system. The
evidence is most convincingly demonstrated for D-serine through
its action as a co-agonist at the N-methyl-D-aspartate recep-
tor (NMDAR), a major glutamate receptor subtype, involved in
synaptic plasticity (Mothet et al., 2000). An essential role for
D-serine has been demonstrated in long-term potentiation (Yang
et al., 2003), fear conditioning (Li et al., 2013) and nociception
(Wake et al., 2001). Abnormal levels of D-amino acid have been
reported in aging and Alzheimer’s disease but it is only more
recently that, a direct link has emerged between D-serine and
a chronic neurodegenerative disease, amyotrophic lateral sclero-
sis (ALS). ALS is a common adult-onset neuromuscular disease
characterized by selective loss of motor neurons leading to fatal
paralysis with a life-time risk of 1 in 500. At the cellular level, the
hallmark of ALS is the presence of TDP-43-positive ubiquitinated
protein aggregates (Neumann et al., 2006).
The link betweenD-amino acids and disease was first indicated
by findings that D-serine levels are elevated in sporadic ALS and
also in the G93A SOD1 mouse model of ALS (Sasabe et al., 2007,
2012). Our own studies have identified a pathogenic mutation
(R199W) in the enzyme that degrades D-serine, D-amino acid
oxidase (DAO) and co-segregates with disease across multiple
generations in a kindred with familial ALS (Mitchell et al., 2010).
The familial form of ALS constitutes 10% of all cases of ALS and
to-date the causal genes in over 70% of these families have been
identified, the most common being C9orf72, a gene of unknown
function, Cu/Zn-dependent superoxide dismutase (SOD1), TAR
DNA binding protein 43 (TARDBP) and fused in sarcoma (FUS).
Arginine199 is highly conserved across species from bacteria to
man and lies within the active site close to the FAD and sub-
strate binding sites of the enzyme. The effect of the R199W-DAO
mutation is very profound abolishing enzyme activity (Mitchell
et al., 2010). Furthermore, R199W-DAO, but not wild-type DAO,
has marked toxic effects in motor neurons promoting apopto-
sis following transfection of primary motor neuron cultures and
causing protein aggregate formation in motor neuron cultures
(Mitchell et al., 2010). To further understand the involvement of
D-amino acids and DAO in ALS, we used a cohort of sporadic
ALS cases and controls (Anagnostou et al., 2010) to characterize
their distribution in spinal cord and investigated the pathogenic
effects of the FALS-associated mutation in cell culture.
D-SERINE AND DAO DISTRIBUTION IN SPINAL CORD
The distribution of DAO, D-serine and serine racemase (SR), the
major biosynthetic for D-serine, in mammalian brain has been
characterized extensively (Moreno et al., 1999; Williams et al.,
2006; Verrall et al., 2007; Balu et al., 2014). DAO has a selective
distribution, being particularly abundant in cranial motor nuclei
such as facial nerve nucleus, magnocellular cells of the reticular
formation, deep cerebellar nuclei and is present in cerebellum in
both Purkinje cells and Bergmann glial cells (Mitchell et al., 2010;
Paul and de Belleroche, 2012). Lower levels of DAO are generally
found in forebrain compared to hind brain.
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In human spinal cord DAO and D-serine immunoreactivity is
prominent in motor neurons (Paul et al., 2014). DAO immunore-
activity is highly concentrated in spinal cord motor neurons,
fibers and glial cells and at the cellular level, the distinct perox-
isomal localization of DAO is evident (Paul et al., 2014). D-serine
appears punctate and in vesicle-like structures throughout the
cytosol of motor neurons and glial cells. SR is also present in both
motor neuron and glial cells in control spinal cord. In ALS, levels
of D-serine, DAO, and SR in spinal cord are all severely depleted
reflecting the substantial loss of motor neurons with disease.
Whilst SR-positive motor neurons loss occurs in ALS, SR-positive
glial cells are substantially increased in ALS (Paul et al., 2014).
EFFECT OF MUTANT-DAO EXPRESSION IN VIVO
A naturally occurring point mutation in DAO (G181R) has been
identified in a mouse line, which shows abnormal locomotor
activity (Almond et al., 2006) and like R199W-DAO has impaired
DAO activity. Recently, this line (ddY/DAO−mice) was back-
crossed with C57BL/6J mice and maintained as homozygotes
(DAO−/−) in order to study the motor phenotype in more detail
(Sasabe et al., 2012). Motor phenotype was markedly affected
in these G181R-DAO mice. At 8 months abnormal reflexes were
detected, characterized by retraction of hind limbs, as seen in the
G93A SOD1 mouse model of motor neuron disease, which was
accompanied by a reduction in motor neuron number of 24%
in DAO−/− mice. At 15 months, axonal degeneration was evi-
dent with muscle atrophy and increased ubiquitination was also
detected at this time point. The study also showed that D-serine
accumulated in the spinal cord during disease progression in the
G93A SOD1 mouse model (Sasabe et al., 2012).
PATHOGENIC MECHANISMS IN CELL CULTURE
APOPTOSIS
In order to dissect out the mechanisms of R199W-DAO-mediated
toxicity, we studied effects occurring both in motor neurons and
astrocytes, using a motor neuron cell line, NSC-34, and the C6
glioma cell line (Paul et al., 2014). Cells were cultured sepa-
rately and in co-culture in order to characterize the different
cellular actions of the mutant protein and also the interaction
between neuronal and glial cells. Our earlier studies in primary
cultures showed that not only did direct transduction of motor
neurons with R199W-DAO cause apoptosis but also co-culture
of glial cells expressing R199W-DAO with motor neurons lacking
R199W-DAO had a similar effect on the viability of neuronal cells
(Mitchell et al., 2010).
C6 cell lines stably expressing wild-type or R199W-DAO were
established and shown to exhibit low levels of apoptosis in culture
(Figure 1A; Paul et al., 2014). For co-culture studies, these cells
were cultured on a membrane insert suspended above differenti-
ated NSC-34 cells using a transwell system. Although physically
separated, the two cell lines shared the same medium. We co-
cultured DAO (wild-type or R199W-DAO) expressing glial cells
with NSC-34 cells and after 48 h in co-culture, NSC-34 cells were
stained for annexin-V (an early apoptotic marker) and 7-AAD
(a late apoptotic marker) and then assayed using flow cytom-
etry. Co-culture of NSC-34 cells with R199W-DAO expressing
glial cells increased annexin-V staining compared to co-culture
with wild-type-DAO expressing glial cells (Figure 1B; Paul et al.,
2014).
These results suggested that dysfunction of D-serine
metabolism caused by a mutant allele leads to the release of
a diffusible agent from glial cells that affects the viability of
NSC-34 cells. One possible candidate is extracellular D-serine, a
co-agonist at the NMDAR, which facilitates excitatory activity at
this receptor. The source of D-serine may be activity-dependent
release from either neuronal or astrocytic cells (Mothet et al.,
2005; Kartvelishvily et al., 2006; Panatier et al., 2006; Martineau
et al., 2013) and furthermore may involve amino acid trans-
porters (Shao et al., 2009) on neurons that mediate release of
D-serine and glycine that subsequently modulates NMDAR
activity (Rosenberg et al., 2013). This was confirmed using
5,7-dichloro-4-hydroxyquinoline-2-carboxylic acid (DCKA), a
selective antagonist at the glycine/D-serine binding site of the
NMDA receptor which effectively prevents cell death due to
NMDA or simulated ischemia in brain slices (Katsuki et al.,
2004). We found that the increased apoptosis in NSC-34 cells
induced by R199W DAO expressing glial cells was significantly
attenuated by DCKA (Figure 1C; Paul et al., 2014). These results
provide substantial evidence for a non-cell autonomous effect
mediated by glia (Ilieva et al., 2009) that is similar to that
reported when glial cells from G93A-SOD1 transgenic mice are
co-cultured with motor neurons (Nagai et al., 2007) and indicates
that glial-motor neuron interactions play an important role in
ALS pathogenesis.
AUTOPHAGY
Since R199W-DAO expressing motor neurons are characterized
by ubiquitinated protein aggregates (Mitchell et al., 2010), we
measured the effects of R199W DAO on the major pathways
involved protein degradation, the ubiquitin-proteasome system
(UPS) and autophagy, both of which were triggered by R199W-
DAO. The most substantial flux was seen in autophagy, with
large increases occurring in the generation of autophagosomes
associated with increased levels of the microtubule associated
protein light chain 3-II (LC3-II) protein, a marker/mediator of
autophagosome formation. Conversion of LC3-I to its lipidated
form LC3-II denotes an induction of autophagy associated with
an increase in autophagosomes (Kabeya et al., 2000). Following
the co-transfection of NSC-34 cells with GFP-tagged LC3 and
RFP-tagged DAO, a five-fold increase in the number of cells
containing >10 GFP-tagged LC3 puncta/autophagosomes was
evident in cells expressing RFP-tagged R199W DAO compared to
wild-type or vector transfected cells (Figures 2A–C; Paul et al.,
2014).
Increased LC3-positive autophagosome production also
occurred in cells expressing G183R DAO, the human equivalent
of a spontaneously occurring mutation in mice, which abol-
ishes enzyme activity and leads to enhanced NMDA receptor
activity in vivo (Almond et al., 2006). Levels of LC3-II protein
were quantified by Western blot analysis and showed a similar
magnitude of effect for both DAO mutations (Figure 2D; Paul
et al., 2014). Increased LC3-II levels are also observed in spinal
cord motor neurons of the SOD1 (G93A) mouse model of ALS
(Zhang et al., 2011) and in ALS motor neurons (Sasaki, 2011).
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FIGURE 1 | R199W DAO promotes apoptosis in glial cells and neighboring
neuronal cells. Annexin V levels in (A) C6 glial cells permanently expressing
WT or R199W DAO, (B) NSC-34 neuronal cells co-cultured with C6 glial cells,
(C) NSC-34 cells treated with DCKA co-cultured with C6 cells and
immunoblotted and quantified. Significant One-Way ANOVA subject to
post-hoc testing with Bonferroni correction (A,B). Paired t-test used in (C).
Values are means ± s.e.m., for P-values shown, ∗P < 0.05, ∗∗P < 0.01. n = 5,
except (C)where n = 3. It should be noted that levels of annexin V in adherent
cells are higher than those obtained in cell suspensions due to some activation
caused by mechanical cell detachment. Data is taken from Paul et al. (2014).
To determine whether the increased autophagic flux was linked
to co-agonist regulation of NMDAR activity, we tested the effect
of DCKA on LC3-II induction. DCKA significantly reduced the
increase in LC3-II levels in R199W-DAO expressing cells but had
no effect in WT-DAO expressing cells (Figure 2E; Paul et al.,
2014) strongly suggesting that the increased autophagy caused by
R199W-DAO was triggered via the NMDAR (Paul et al., 2014). A
similar example of NMDAR activation leading to an increase in
LC3-II and autophagic-mediated cell death has previously been
demonstrated in cerebellar granule cells (Sadasivan et al., 2010).
These findings further substantiate the potential contribution of
the NMDAR in triggering the pathogenic effects of mutant DAO.
IS THERE A ROLE FOR GLYCINE, A SECOND CO-AGONIST AT
THE NMDA RECEPTOR IN ALS PATHOGENESIS? CSF AND
PLASMA GLYCINE LEVELS ARE ELEVATED IN ALS
The findings both in ALS spinal cord and SOD1 mice that
D-serine is elevated compared to controls provide a potential
link between D-serine and ALS pathogenesis. However autopsy
cases generally represent end-stage conditions where extensive
motor neuron loss has already occurred and extensive degener-
ation is in progress, which obscures early events. Previous studies
in our laboratory examining levels of common amino acids in
CSF in ALS showed significant increases in four amino acids
(L-threonine, glycine, L-valine and L-phenylalanine) compared to
controls, the greatest change being an increase of 57% in glycine
which suggested a potential impairment in glycine transport (de
Belleroche et al., 1984). In a subsequent follow-up study, we
showed that glycine clearance from plasma after a glycine chal-
lenge was significantly impaired in classical ALS (n = 23) and
in two overlapping ALS-like conditions, progressive bulbar palsy
and primary lateral sclerosis (total ALS, n = 32), compared to
normal controls and a control neurological group consisting of
conditions associated with similar muscle loss (total controls,
n = 26) (Lane et al., 1993). The most marked difference between
ALS and controls was a greater than 2-fold increase in CSF lev-
els of glycine at 2.5 h, at which time glycine levels have reached a
maximum.
An impaired clearance of both glycine, as indicated from these
results (Lane et al., 1993), and also of D-serine as indicated from
the studies of (Sasabe et al., 2007, 2012) in ALS, could both
lead to a potentiation of NMDA receptor currents. The balance
between these co-agonists is likely to be complex and selectively
modulated by multiple factors. However, an understanding of the
mechanisms regulating the selective recruitment and properties
of either glycine or D-serine in the modulation of NMDAR activ-
ity is now emerging and shows both a functional specificity for
each co-agonist and interdependence that further shows regional
variation.
In hippocampus and amygdala (Li et al., 2009, 2013), D-serine
is thought to serve as the endogenous agonist responsible for
tonic activation mediating NMDAR-mediated currents (EPSCs)
in response to low levels of synaptic activity, which effect
is diminished by DAO but not glycine oxidase (GO), and
is reduced in serine racemase knock-out mice SR−/−, where
D-serine synthesis is reduced. On the other hand, glycine
facilitates NMDAR-mediated currents after afferent stimula-
tion, diminished by GO but not by DAO (Li et al., 2013).
Under these conditions, activity-dependent release of glycine
from astrocytes is sufficient to support synaptic activation.
Thus, both co-agonists are likely to play a role in the induc-
tion of LTP, as depletion of D-serine by DAO or SR−/−
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FIGURE 2 | R199W DAO promotes autophagy in neuronal cells.
NSC-34 cells were co-transfected with RFP-tagged DAO and GFP-tagged
LC3. (A) Representative immunofluorescence images show RFP-DAO
(red) GFP-LC3 (green) and DAPI nuclear stain (blue). Scale bar: 20 um.
Number of (B) vector or DAO transfected cells or (C) cells containing
>10 GFP-LC3 puncta or autophagosomes. Rapamycin induced autophagy
was used as a positive control. (D) Levels of LC3-II were calculated
using densitometry and normalized to protein levels of RFP-vector. (E)
NSC-34 cells were treated with DCKA, immunoblotted and quantified.
Significant One-Way ANOVA with Friedman’s test subject to post-hoc
testing with Dunn’s multiple comparison test (B–D) or Two-Way ANOVA
(E). Values are means ± s.e.m., for P-values shown, ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001. n = 4, except (B,C) where n = 6. Data is
taken from Paul et al. (2014).
knockdown or depletion of glycine by GO reduce LTP (Li et al.,
2013).
The interplay between glycine site co-agonists has not
been extensively characterized in brain stem and spinal cord.
However, studies in rat hypoglossal motor neurons suggest
that an increase in synaptically released glycine in response
to metabolic stress may play a role in exacerbating NMDA
receptor-mediated excitotoxicity in motor neurons (Kono et al.,
2007). Regardless of the co-agonist, a selective antagonist
for the glycine site on the NMDAR may have therapeu-
tic potential in reducing excitotoxicity, as evidenced from
the use of DCKA in the cell culture studies described
above.
A GENERIC MODEL OF NEURODEGENERATION
Experimental evidence obtained to date highlights the selective
localization of DAO in spinal cord motor neurons, brain stem
motor nuclei, cerebellum and other CNS centers involved in
motor control. DAO is also found in glial cells in spinal cord
and cerebellum. This distribution of enzyme activity is consistent
with the lower levels of D-serine found in posterior brain com-
pared to forebrain. The primary findings that implicate D-serine
in ALS and potentially in neurodegeneration in general are that
elevated levels of D-serine in spinal cord are found in ALS and the
SOD1 mouse model of ALS (Sasabe et al., 2007, 2012). This sug-
gests that elevated levels of D-serine contribute to motor neuron
degeneration which is supported by the findings concerning two
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mutations in DAO that virtually abolish enzyme activity, one that
is associated in familial ALS in man and a second found in the
mouse that causes a motor phenotype similar to that seen in the
SOD1 mouse model of ALS (Sasabe et al., 2012). In contrast,
SR deletion that reduces D-serine levels protects against cerebral
ischemia and excitotoxicity (Mustafa et al., 2010).
In order to further substantiate this concept, we have
explored the potential toxic properties of the FALS-associated
R199W-DAO mutation in cell culture and have shown that
whether expressed in astrocytes or motor neurons the mutation
promotes apoptosis but most interesting when expressed in glial
cells the mutant protein is able to initiate apoptosis in neigh-
boring neurons in co-culture that lack the mutation. The way
in which this effect is transmitted between cells appears to be
crucially dependent on the presence of an NMDAR co-agonist
as the effect is blocked by the selective antagonist DCKA. In the
situation where DAO is inhibited due to the presence of a muta-
tion, D-serine levels are elevated (Sasabe et al., 2007) and could
potentially promote NMDAR-mediated excitotoxic cell death.
Furthermore, D-serine has been shown to increase the affinity of
glutamate binding to the NMDAR even in the absence of changes
in glutamate levels (Crow et al., 2012).
It is of considerable importance to note that increased synthe-
sis of D-serine by neuronal and glial SR is known to be activated
by cellular stressors such as AMPA, amyloid-beta and lipopolysac-
charide (Wu and Barger, 2004: Wu et al., 2007; Paul et al., 2014)
which may lead to the elevated levels of D-serine found in spo-
radic cases of ALS. These and other factors such as oxidative stress
and ageing may further contribute to the etiology of sporadic
ALS and other neurodegenerative conditions. Most importantly,
future studies are needed to determine the spatial distribution of
D-serine and glycine uptake mechanisms and the different pop-
ulations of NMDARs in the spinal cord that may be gated by
different co-agonists.
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